Ruste, Rhianna .

HRN: 28-98-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/02/2026
06/09/2026
IV
52mg
Q8H
Amoebiasis
Checking Initial Appropriateness 
06/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2026
06/09/2026
IV
52mg
Q8H
Amoebiasis
Checking Initial Appropriateness 
06/02/2026
CEFUROXIME 1.5GM (VIAL)
06/02/2026
06/09/2026
IV
150mg
Q8H
PCAP C
Checking Initial Appropriateness 
06/06/2026
MUPIROCIN 2%, 15G (TUBE)
06/06/2026
06/13/2026
TOPICAL
12g
BID
Acute Skin Infection
Checking Initial Appropriateness 
06/07/2026
CEFTRIAXONE 1G (VIAL)
06/07/2026
06/14/2026
IV
210
Q12H
PCAP C
Checking Initial Appropriateness 
06/08/2026
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
06/08/2026
06/15/2026
PO
1.0ml
BID
PCAP
Checking Initial Appropriateness 
06/08/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/08/2026
06/09/2026
PO
2ml
Q8hrs
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: